What Researchers Did
Researchers conducted two randomized controlled trials in France to evaluate the efficacy of hyperbaric oxygen therapy compared to normobaric oxygen or different HBO regimens in 385 patients with acute domestic carbon monoxide poisoning.
What They Found
In patients with transient loss of consciousness (Trial A), there was no significant difference in 1-month complete recovery rates between those receiving hyperbaric oxygen therapy (61%) and those receiving normobaric oxygen (58%). For comatose patients (Trial B), complete recovery rates were significantly lower with two hyperbaric oxygen sessions (47%) compared to one session (68%).
What This Means for Canadian Patients
For Canadian patients experiencing carbon monoxide poisoning with transient loss of consciousness, hyperbaric oxygen therapy may not offer additional benefit over standard normobaric oxygen. Furthermore, comatose patients might experience worse outcomes with multiple hyperbaric oxygen sessions compared to a single session.
Canadian Relevance
This study was conducted in France and has no direct Canadian connection.
Study Limitations
A limitation of this study is that it was conducted at a single critical care unit, which may limit the generalizability of the findings to other settings or patient populations.